GLOBUS MEDICAL INCGMED決算レポート
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
GMED Q4 2025 Key Financial Metrics
売上高
$826.4M
粗利益
$565.3M
営業利益
$169.3M
純利益
$140.6M
粗利益率
68.4%
営業利益率
20.5%
純利益率
17.0%
前年比成長
25.7%
EPS
$1.01
資金フロー
GLOBUS MEDICAL INC Q4 2025 財務サマリー
GLOBUS MEDICAL INC reported revenue of $826.4M (up 25.7% YoY) for Q4 2025, with a net profit of $140.6M (up 430.4% YoY) (17.0% margin). Cost of goods sold was $261.1M, operating expenses totaled $396.0M.
主要財務指標
| 総売上高 | $826.4M |
|---|---|
| 純利益 | $140.6M |
| 粗利益率 | 68.4% |
| 営業利益率 | 20.5% |
| 報告期間 | Q4 2025 |
売上内訳
GLOBUS MEDICAL INC Q4 2025 revenue of $826.4M breaks down across 3 segments, led by Other at $391.8M (47.4% of total).
| セグメント | 売上高 | 構成比 |
|---|---|---|
| Other | $391.8M | 47.4% |
| Nevro Merger Agreement | $293.6M | 35.5% |
| Enabling Technologies | $141.0M | 17.1% |
GLOBUS MEDICAL INC 年度売上推移
GLOBUS MEDICAL INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.9B). Click any linked year to see what changed vs the prior 10-K.
GLOBUS MEDICAL INC 四半期売上・純利益の履歴
GLOBUS MEDICAL INC quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 四半期 | 売上高 | 売上前年比 | 純利益 | 純利益率 |
|---|---|---|---|---|
| Q4 2025 | $826.4M | +25.7% | $140.6M | 17.0% |
| Q3 2025 | $769.0M | +22.9% | $119.0M | 15.5% |
| Q2 2025 | $745.3M | +18.4% | $202.8M | 27.2% |
| Q1 2025 | $598.1M | -1.4% | $75.5M | 12.6% |
| Q4 2024 | $657.3M | +6.6% | $26.5M | 4.0% |
| Q3 2024 | $625.7M | +63.1% | $51.8M | 8.3% |
| Q2 2024 | $629.7M | +115.9% | $31.8M | 5.0% |
| Q1 2024 | $606.7M | +119.3% | $-7.1M | -1.2% |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $606.7M | $629.7M | $625.7M | $657.3M | $598.1M | $745.3M | $769.0M | $826.4M |
| 前年比成長 | 119.3% | 115.9% | 63.1% | 6.6% | -1.4% | 18.4% | 22.9% | 25.7% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $4.94B | $4.99B | $5.09B | $5.25B | $4.71B | $4.96B | $5.10B | $5.30B |
| 総負債 | $1.02B | $1.02B | $1.02B | $1.07B | $623.1M | $665.4M | $696.8M | $729.5M |
| 株主資本 | $3.92B | $3.98B | $4.07B | $4.18B | $4.09B | $4.30B | $4.40B | $4.57B |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $52.4M | $54.3M | $203.7M | $210.3M | $177.3M | $77.9M | $249.7M | $248.6M |